FurchnerJ. E.RichmondC. R.DrakeG. A. (1971). Comparative metabolism of radionuclides in mammals—V. Retention of 192Ir in the mouse, rat, monkey and dog. Health Phys. 20, 375–382.
2.
HolbrookD. J.Jr.WashingtonM. E.LeakeH. B.BrubakerP. E. (1975). Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium. Environ. Health Perspectives. 10, 95–101.
3.
ICRP Task Group on Lung Dynamics (1966). Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys. 12, 173–207.
4.
ICRP Publication 23. Report of the Task Group on Reference Man. Pergamon Press, Oxford, 1975.
5.
LangeR. C.SpencerR. P.HarderH. C. (1972). Synthesis and distribution of a radiolabelled antitumor agent: cis-diamminedichloroplatinum (II). J. Nucl. Med. 13, 328–330.
6.
LitterstC. L.GramT. E.DedrickR. L.LeroyA. F.GuarinoA. M. (1976). Distribution and disposition of platinum following intravenous administration of cis-diamminedichoroplatinum (II) (NSC119875) to dogs. Cancer Res. 36, 2340–2355.
7.
MooreW.Jr.HysellD.CrockerW.StaraJ. (1975). Biological fate of a single administration of 191Pt in rats following different routes of exposure. Environ. Res. 9, 152–158.
8.
MooreW.Jr.MalanchukM.CrockerW.HysellD.CohenA.StaraJ. F. (1975). Whole body retention in rats of different 191Pt compounds following inhalation exposure. Environ. Health Perspectives12, 35–39.
9.
SchlesingerT.ManakaC.WolfW. (1977). Dose estimation for radioactive cis-dichlorodiammine platinum (195m)II—a new radiopharmaceutical. In: Proc IVth Int. Cong. IRPA, Paris, April 1977, Vol. 4, pp. 1417–1419.
10.
SmithP. H. S.TaylorD. M. (1974). Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum(II) in man. J. Nucl. Med. 15, 349–351.
11.
YoakumA. M.StewartP. L.SterrettJ. E. (1975). Method development and subsequent survey analysis of biological tissues for platinum, lead and manganese content. Environ. Health Perspectives. 10, 85–93.